Delivery Order SPE2DX22D0049-SPE2D826FA4BE

AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $49,902.34 by the Defense Logistics Agency's Medical Supply Chain with an ultimate completion date of February 3, 2026. This competitively awarded, firm fixed-price contract contains no set-aside designation, reflecting the contractor's ability to compete on a full and open basis for federal procurement requirements. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.

AmerisourceBergen Drug Corp supplies a broad portfolio of pharmaceutical products and medical commodities to support federal medical procurement needs, including brand-name and generic medications, vaccines, medical devices, and specialized healthcare supplies across multiple therapeutic domains. The company operates as a subsidiary of Cencora, Inc. (doing business as AmerisourceBergen), which holds the primary $999,999,999.00 IDC with the Defense Logistics Agency Troop Support Medical through December 2031. These contract vehicles enable the company to fulfill critical medical supply requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems serving military personnel, veterans, and federal beneficiaries worldwide.